DESONIDE News

DESONIDE currently has 8 news articles, with 35 predicted indications.

This page combines the AI-predicted indications for DESONIDE with the latest health news. Indications highlighted in orange have recent news coverage.

Drug Information

Evidence level: L5
Predicted indications (35):
- occupational dermatitis (99.0%)
- atopic eczema (99.0%)
- discoid lupus erythematosus (99.0%)
- chronic cutaneous lupus erythematosus (99.0%)
- otitis externa (99.0%)
- primary cutaneous T-cell lymphoma (99.0%)
- Crohn's colitis (99.0%)
- seborrheic keratosis (99.0%)
- granuloma annulare (99.0%)
- exanthem (disease) (99.0%)
- dermatitis, atopic (99.0%)
- contact dermatitis (99.0%)
- Crohn disease (99.0%)
- inflammatory bowel disease (99.0%)
- lichen disease (99.0%)
- primary cutaneous T-cell non-Hodgkin lymphoma (99.0%)
- neurodermatitis (99.0%)
- lupus erythematosus (99.0%)
- external ear disease (99.0%)
- seborrheic dermatitis (99.0%)
- vasomotor rhinitis (99.0%)
- allergic rhinitis (99.0%)
- allergic asthma (99.0%)
- intrinsic asthma (99.0%)
- asthma (99.0%)
- polyp of vocal cord (99.9%)
- polyp of middle ear (99.9%)
- polyp of external auditory canal (99.9%)
- polyp of frontal sinus (99.9%)
- polyp of ureter (99.9%)
- polyp of vulva (99.9%)
- fibroepithelial polyp (99.9%)
- neoplastic polyp (99.9%)
- epulis (99.9%)
- uterine polyp (99.9%)